SECURITY NATIONAL BANK OF SIOUX CITY IOWA /IA/
BankPosition in XLO — Xilio Therapeutics, Inc.
CIK 894309
SIOUX CITY, IA
Position in XLO
as of Jun 30, 2026
· filed Sep 18, 2026
Position Value
$3,075
New position
Shares Held
321
first reported quarter
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 27 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026SECURITY NATIONAL BANK OF SIOUX CITY IOWA /IA/ holds $165,607 across 6 Biotechnology names. XLO ranks #5 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
26,650 | $63,960 | |
| 2 | CGEN |
Compugen Ltd
|
25,000 | $53,500 | |
| 3 | ONCY |
Oncolytics Biotech Inc
|
33,255 | $31,592 | |
| 4 | IPSC |
Century Therapeutics, Inc.
|
5,000 | $12,250 | |
| 5 | XLO |
Xilio Therapeutics, Inc.
This page
|
321 | $3,075 | |
| 6 | AVXL |
Anavex Life Sciences Corp.
|
475 | $1,230 |
All Filings in XLO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,075 | 321 | Shares | Sole | 2026-09-18 | |
| No filing history on record for this holder in this stock. | ||||||